Refine
Is part of the Bibliography
- yes (151)
Year of publication
Document Type
- Journal article (122)
- Doctoral Thesis (28)
- Preprint (1)
Keywords
- heart failure (16)
- echocardiography (9)
- Herzinsuffizienz (8)
- cardiomyopathy (6)
- magnetic resonance imaging (6)
- mitochondria (6)
- acute heart failure (5)
- myocardial infarction (5)
- prognosis (5)
- akute Herzinsuffizienz (4)
- atrial fibrillation (4)
- cardiovascular genetics (4)
- ischemic stroke (4)
- mortality (4)
- Herzhypertrophie (3)
- Herzmuskelkrankheit (3)
- MRI (3)
- Magnetic resonance imaging (3)
- deep learning (3)
- desmin (3)
- hypertension (3)
- radial (3)
- reactive oxygen species (3)
- 7 T (2)
- 7T (2)
- Arrhythmie (2)
- Barth syndrome (2)
- Beschleunigungssensor (2)
- CRISPR/Cas9 (2)
- Chronotrope Inkompetenz (2)
- DSG2 (2)
- EUROASPIRE (2)
- Fabry disease (2)
- Fluoreszenz (2)
- GFAP (2)
- Guidelines (2)
- Heart failure (2)
- Herzfrequenz (2)
- Herzmuskelzelle (2)
- Herzschrittmacher (2)
- Induzierte pluripotente Stammzelle (2)
- Koronare Herzkrankheit (2)
- Mitochondrium (2)
- Natrium-Calcium-Austauscher (2)
- Pulswelle (2)
- Quality of life (2)
- TRP-Kanäle (2)
- TRPC4 (2)
- accelerometer-sensor (2)
- anxiety (2)
- arrhythmia (2)
- arrhythmogenic cardiomyopathy (2)
- atherosclerosis (2)
- biomarkers (2)
- carbohydrates (2)
- cardiac (2)
- cardiac device (2)
- cardiac magnetic resonance (2)
- cardiac magnetic resonance imaging (2)
- cardiac metabolism (2)
- cardiogenetics (2)
- cardiolipin (2)
- cardiology (2)
- cardiovascular diseases (2)
- cardiovascular implantable electronic device (2)
- cardiovascular risk factors (2)
- chronic heart failure (2)
- chronotropic incompetence (2)
- coronary heart disease (2)
- depression (2)
- desmosomes (2)
- diabetes mellitus (2)
- diffusion tensor imaging (2)
- dilated cardiomyopathy (2)
- ejection fraction (2)
- heart (2)
- heart rate (2)
- inflammation (2)
- left ventricular ejection fraction (2)
- mapping (2)
- morbidity (2)
- mouse (2)
- myocardial work (2)
- neural networks (2)
- norepinephrine transporter (2)
- positron emission tomography (2)
- quality (2)
- quality of life (2)
- regulatory T cells (2)
- respiratory chain (2)
- restrictive cardiomyopathy (2)
- secondary prevention (2)
- segmentation (2)
- theranostics (2)
- thorax (2)
- translational research (2)
- troponin (2)
- whole exome sequencing (2)
- 3D echocardiography (1)
- 3D printing (1)
- 3 T (1)
- 4D flow MRI (1)
- <sup>18</sup>F-FDG (1)
- <sup>68</sup>Ga-Pentixafor (1)
- ACC/AHA classification (1)
- ACM (1)
- AHF (1)
- AHF-Register Würzburg (1)
- AI (1)
- ARVC (1)
- ASE formula (1)
- Acylcarnitin (1)
- Addison's disease (1)
- Alzheimer's disease (1)
- Angiotensin II (1)
- Aorta (1)
- Aortenklappe (1)
- Arrhythmogene Kardiomyopathie (1)
- Arrhythmogenic cardiomyopathy (1)
- Arterielle Gefäßsteifigkeit (1)
- Arteriosklerose (1)
- Asthma (1)
- Atherosclerosis (1)
- B (1)
- B-MYB (1)
- B0 (1)
- BDNF (1)
- Barth Syndrome (1)
- Bildgebendes Verfahren (1)
- Biobank (1)
- Bioluminescence (1)
- Blood pressure (1)
- Brain atrophy (1)
- Breathing (1)
- Brownian ratchet (1)
- Bypass (1)
- CD4+ T-cells (1)
- CMR (1)
- COVID-19 (1)
- CRISPR-Cas Systems (1)
- CRISPR/Cas-Methode (1)
- CXCR4 (1)
- Calcium (1)
- Calciumkanal (1)
- Calciumtransport (1)
- Calpain (1)
- Cardiac (1)
- Cardiac Efficiency (1)
- Cardiac MRI (1)
- Cardiac ventricles (1)
- CardioMEMS™ HF system (1)
- CardioMEMS™ HF-System (1)
- Cardiovascular disease (1)
- Cardiovascular diseases (1)
- Cardiovascular magnetic-resonance (1)
- Carotis Intima Media Dicke (1)
- Cavβ subunit (1)
- Cerebral-ischemia (1)
- Chronic heart failure (1)
- Chronic heart-failure (1)
- Chronic kidney disease (1)
- Chronic obstrusive pulmonary disease (1)
- Chronische Herzinsuffizienz (1)
- Chronische Nierenerkrankung (1)
- Clinical decision support system (1)
- Clinically silent stroke (1)
- Cognitive decline (1)
- Cognitive impairment (1)
- Collaboration (1)
- Coronary artery disease (1)
- Coronary heart disease (1)
- Cotransporter 2 inhibition (1)
- Cranial sutures (1)
- DSC2 (1)
- DTI (1)
- Data acquisition (1)
- Deep learning (1)
- Diagnostic medicine (1)
- Diffusion tensor imaging (1)
- Diffusionsgewichtete Magnetresonanztomografie (1)
- Dilated Cardiomyopathy with Ataxia (1)
- Diseases (1)
- Dokumentationsqualität (1)
- Double-blind (1)
- E/e’ (1)
- ERK1/2 (1)
- Echocardiography (1)
- Echokardiographie (1)
- Echtes WRF (1)
- Eigenvectors (1)
- Embryos (1)
- Endorganschaden (1)
- English version (1)
- Enhancer elements (1)
- Entscheidungsunterstützungssystem (1)
- Enzyme replacement therapy (1)
- Excitation-Transcription-Coupling (1)
- Extracellular volume (1)
- FKBP52 (1)
- Fabry Disease (FD) (1)
- Fabry-associated pain (1)
- GDNF (1)
- Gb3 and lyso-Gb3 biomarkers (1)
- Gefäßalter (1)
- Genanalyse (1)
- Germany (1)
- Glatiramer acetate (1)
- Glial fibrillary acidic protein (1)
- HFpEF (1)
- HMDP hydroxymethylene diphosphonate (1)
- Head-injury (1)
- Heart (1)
- Heart Failure (1)
- Hemodynamic depression (1)
- Herzdekompensation (1)
- Herzthoraxchirurgie (1)
- Hesse (1)
- HiGHmed (1)
- Hindbrain (1)
- Hospitalization (1)
- Hypertension (1)
- Hypertrophic cardiomyopathy (1)
- Hämodialyse (1)
- IP3 signaling (1)
- IP3-Signaling (1)
- Immunkardiologie (1)
- Immunocardiology (1)
- Immunologie (1)
- Immunophilin (1)
- Induced Pluripotent Stem Cells (1)
- Inflammation (1)
- Inositoltrisphosphat (1)
- Integrated Palliative care outcome scale (1)
- Intensivtransport (1)
- Interhospitaltransfer (1)
- Intravascular coagulation (1)
- Journal of Nuclear Cardiology (1)
- KHK (1)
- KWIC (1)
- Kandidatengen (1)
- Kardiologie (1)
- Kernspintomografie (1)
- Kognitive Defizite (1)
- Kreatinin (1)
- Künstliche Intelligenz (1)
- L-type calcium channels (1)
- LMNA (1)
- LTCC-independent function of Cavβ (1)
- LV Function (1)
- LV dilatation (1)
- LVNC (1)
- Langzeitbeatmung (1)
- Langzeitlagerung (1)
- Lebensqualität (1)
- MOLLI (1)
- Management (1)
- Manifestation (1)
- Massive parallele Sequenzierung (1)
- Measurement (1)
- Medicine (1)
- Mellitus (1)
- Memory dysfunction (1)
- Mice (1)
- MitoQ (1)
- Mitochondrialer Uniporter (MCU) (1)
- Mitochondrialer Uniporter Knock out (MCU-KO) (1)
- Mitofusin2 (1)
- MitraClip (1)
- Model (1)
- Molecular-weight heparin (1)
- Mortality (1)
- Mortalität (1)
- Mouse models (1)
- Mutation (1)
- Myb-MuvB (1)
- Myocardial Work (1)
- Myocardial fibrosis (1)
- Myocardial infarction (1)
- Myocardial-perfusion SPECT (1)
- Myokardinfarkt (1)
- NEC (1)
- NET (1)
- NOAC (1)
- NSG animals (1)
- NT-proBNP (1)
- NT‐proBNP (1)
- Na+/K+-ATPase (1)
- Natrium-Kalium-Pumpe (1)
- Neurodegeneration (1)
- Neurons (1)
- NfL (1)
- Niereninsuffizienz (1)
- OXPHOS (1)
- Oxygen (1)
- PKA (1)
- PKP2 (1)
- PWV (1)
- Pain questionnaire (1)
- Palliativmedizin (1)
- Placebo-controlled trial (1)
- Plasma (1)
- Prevalence (1)
- Prognostic impact (1)
- Protons (1)
- Pseudo-WRF (1)
- Pulmonary imaging (1)
- RKIP (1)
- ROS (1)
- Raman micro-spectroscopy (1)
- Rats (1)
- Risiko (1)
- Risk-factors (1)
- Röntgen-Thorax (1)
- S-glutathionylation (1)
- SAR safety (1)
- SASHA (1)
- SF-36 (1)
- SGLT2 inhibitors (1)
- SPECT (1)
- SR/Mitochondriales Feedback (1)
- ST-elevation myocardial infarction (1)
- STAAB Cohort Study (1)
- STEMI (1)
- Scar (1)
- Score (1)
- Segmentation (1)
- Selbstwirksamkeit (1)
- Self-efficacy (1)
- Sengers syndrome (1)
- Septal bulge (1)
- Serum (1)
- ShMOLLI (1)
- Shimming (1)
- Skull (1)
- Somites (1)
- Spironolacton (1)
- Stabilität (1)
- Sterblichkeit (1)
- Stiffness (1)
- Stoffwechsel (1)
- Stroke (1)
- Survival (1)
- Swine (1)
- Systole (1)
- T cells (1)
- T-shaped π–π stacking (1)
- T1 mapping (1)
- T1rho (1)
- T1ρ (1)
- TMEM43 (1)
- TRPC (1)
- TRPC-Ionenkanäle (1)
- TT\(_{1rho}\) mapping (1)
- T\(_{1P}\) dispersion (1)
- T\(_{1P}\) mapping (1)
- Tabakkonsum (1)
- Tandem-Peptid (1)
- Task force (1)
- Teichholz formula (1)
- Thrombus formation (1)
- Time measurement (1)
- Tobacco smoking (1)
- Tractography (1)
- Ultrahigh field (1)
- VARS2 (1)
- Valvular heart-desease (1)
- Vaskuläre Funktion (1)
- Ventricular-arrhythmias (1)
- Verdachtsgenerierung (1)
- Versorgungsforschung (1)
- Versorgungsprogramm (1)
- WSS (1)
- Wasted Work (1)
- Weaning (1)
- Weight (1)
- YAP (1)
- Zebrafish (1)
- acid sphingomyelinase (1)
- acute decompensated heart failure (1)
- adaptive immune response (1)
- adverse effects (1)
- age-related hearing loss (1)
- akute Niereninsuffizienz (1)
- alveolar epithelium in vitro model, claudin-1, claudin-3, claudin-4, claudin-5 (1)
- amyloid cardiomyopathy (1)
- amyloidosis (1)
- anaemia (1)
- aneurysm (1)
- antenna (1)
- anti-myocardial (1)
- antibody/autoantibody (1)
- anticoagulation (1)
- antidepressants (1)
- antithrombotic therapy (1)
- anxious depression (1)
- aortic arch (1)
- aortic valve stenosis (1)
- areas (1)
- arterial stiffening (1)
- augmentation (1)
- autoantibody (1)
- basic (1)
- blood coagulation factor XIII (1)
- blood plasma (1)
- blood pressure (1)
- blood pressure monitoring (1)
- blood–brain barrier (1)
- blood–labyrinth barrier (1)
- body (1)
- bolus-based perfusion measurement (1)
- bridging (1)
- cadherins (1)
- calcification (1)
- calcium cycling (1)
- calcium imaging (1)
- calcium signaling (1)
- cancer (1)
- cancer treatment (1)
- candidate genes (1)
- cardiac MRI (1)
- cardiac arrest (1)
- cardiac function (1)
- cardiac imaging (1)
- cardiac training group (1)
- cardioprotective potential (1)
- cardiovascular MR methods (1)
- cardiovascular MRI (1)
- cardiovascular drugs (1)
- cardiovascular magnetic resonance (1)
- cardiovascular magnetic resonance (CMR) (1)
- care tempis (1)
- carotid artery disease (1)
- case report (1)
- catecholamines (1)
- cell biology (1)
- cell staining (1)
- cerebral microbleeds (1)
- channel transport (1)
- chest-x-ray (1)
- cholesterol (1)
- chronic kidney disease (1)
- clinical data warehouse (1)
- clinical routine data (1)
- clinical study (1)
- clinical systems (1)
- cognitive decline (1)
- cognitive impairment (1)
- coherent anti-Stokes Raman scattering (CARS) microscopy (1)
- comorbidity (1)
- comparability (1)
- computational fluid dynamics (1)
- computed tomography (1)
- conformational auto-epitope (1)
- congestion (1)
- contractility (1)
- coronary arteries (1)
- coronary artery bypass grafting (1)
- coronary artery disease (1)
- correction (1)
- cross-cultural comparison (1)
- cyclic peptides/cyclopeptides (1)
- cyclopeptide therapy (1)
- cytokines (1)
- cytotoxic T cells (1)
- data acquisition (1)
- death rates (1)
- deformation (1)
- dementia (1)
- density (1)
- depressive disorder (1)
- design (1)
- desmin-related myopathy (1)
- desminopathy (1)
- desmocollin-2 (1)
- desmoglein-2 (1)
- desmosomal mutations (1)
- diagnostic medicine (1)
- diastolic dysfunction (1)
- diastolic function (1)
- diet (1)
- digital Health (1)
- dilated cardiomyopathy with ataxia (1)
- dilated cardiomyopathy with ataxia (DCMA) (1)
- disease score (1)
- disease severity (1)
- documentation quality (1)
- drug interaction (1)
- drug intoxication (1)
- drug toxicity (1)
- eGFR (1)
- echo planar imaging (1)
- editorial (1)
- elamipretide (1)
- electromagnetics (1)
- electronic data capture (1)
- electronic health records (1)
- electrophysiology (1)
- element (1)
- endovascular treatment (1)
- enhancer (1)
- entropy production (1)
- evidence-based practice (1)
- expert opinion (1)
- fatty acids (1)
- female (1)
- filamin-C (1)
- flow dynamics (1)
- food consumption (1)
- free energy (1)
- free‐breathing (1)
- functional magnetic resonance imaging (1)
- functional mitral regurgitation (1)
- gene panel (1)
- genetics (1)
- giant intracranial aneurysm (1)
- glial damage (1)
- glial fibrillary acidic protein (1)
- glomerular filtration rate (1)
- glucocorticoid replacement therapy (1)
- guideline-directed medical therapy (1)
- guidelines (1)
- haemodialysis (1)
- haemodynamic monitoring (1)
- healing and remodelling processes (1)
- health care (1)
- health policy (1)
- health-related quality of life (1)
- health‐related quality of life (1)
- heart disease (1)
- heart failure training group (1)
- heart failure with mid-range ejection fraction (1)
- heart failure with reduced ejection fraction (1)
- heart structure (1)
- heart valve bypass (1)
- hemodialysis (1)
- heterozygote (1)
- high-field MRI (1)
- hospitals (1)
- human behaviour (1)
- human induced pluripotent stem cells (hiPSC) (1)
- humans (1)
- iPSC-CMs (1)
- iPSC-derived CMs (iPSC-CMs) (1)
- image processing (1)
- images (1)
- imaging techniques (1)
- immune cells (1)
- immunohistochemistry (1)
- immunosenescence (1)
- implementation (1)
- in vitro model system of inherited cardiomyopathies (1)
- in vivo imaging (1)
- in-vivo (1)
- induced pluripotent stem cells (iPSCs) (1)
- infarction size (1)
- infection (1)
- inferior vena cava (1)
- inflammaging (1)
- inherited cardiomyopathies (1)
- insulin tolerance test (1)
- integrated stress response (1)
- intensive care transport (1)
- interhospital transfer (1)
- intermediate filaments (1)
- internal medicine (1)
- interparticle interaction (1)
- ischemic-stroke (1)
- junctions (1)
- kidney (1)
- kidney function (1)
- lactic acidosis (1)
- large animal models (1)
- left ventricular geometric abnormality (1)
- left ventricular geometry (1)
- left ventricular hypertrophy (1)
- left ventricular mass (1)
- left ventricular mass index (1)
- left ventricular performance (1)
- left ventricular remodeling (1)
- left ventricular thrombusv (1)
- left-ventricular function (1)
- lifestyle (1)
- linear regression analysis (1)
- long-term ventilation (1)
- low molecular heparin (1)
- lung (1)
- lymphocyte differentiation (1)
- lymphocytes (1)
- m exercise training (1)
- mHealth (1)
- magnetic resoncance (1)
- major depression (1)
- management (1)
- matched filters (1)
- mavacamten (1)
- meat (1)
- mechanisms (1)
- medical data integration center (1)
- medical informatics initiative (1)
- medical rehabilitation (1)
- meningioma (1)
- metabolism (1)
- metastasis (1)
- mice (1)
- middle aged (1)
- mild (1)
- mitochondria function and morphology (1)
- mitochondrial FAO (1)
- mitochondrialer Ryanodin-Rezeptor (mRyR1) (1)
- mitotic genes (1)
- molecular biology (1)
- molecular imaging (1)
- molecular medicine (1)
- multivariate data analysis (1)
- mutations (1)
- myocardial aging (1)
- myocardial blood flow (1)
- myocardial perfusion reserve (1)
- myocardial work efficiency (1)
- myofilament proteins (1)
- myokardiale Arbeit (1)
- myosin (1)
- natriuretic peptide (1)
- nephrology (1)
- neuroblastoma (1)
- neurodevelopmental disorders / genetics (1)
- neuroendocrine neoplasms (NEN) (1)
- neuroendocrine tumors (NET) (1)
- neurofilament light chain (1)
- neuroinflammation (1)
- neurology (1)
- neuroscience (1)
- neurotrophins (1)
- next generation sequencing (1)
- nicotinamide nucleotide transhydrogenase (1)
- nnU-net (1)
- non-equilibrium thermodynamics (1)
- normal values (1)
- ollimator (1)
- omecamtiv mecarbil (1)
- oncology (1)
- openEHR (1)
- optimization (1)
- oral anticoagulants (1)
- organoid (1)
- outcomes (1)
- oxidative stress (1)
- pCa (1)
- percutaneous mitral valve repair (1)
- pharmacotherapy (1)
- phosphorylation (1)
- pig (1)
- pilot project (1)
- plaque characteristics (1)
- plasma proteins (1)
- post-reconstruction filtering (1)
- postmenopausal women (1)
- postoperative bleeding (1)
- poultry (1)
- power grids (1)
- prostate cancer (1)
- prostate-specific membrane antigen (PSMA) (1)
- public health (1)
- pulmonary artery pressure (1)
- quantitative MRI (1)
- randomized controlled trial (1)
- real-world (1)
- recovery (1)
- reference data (1)
- rehabilitation (1)
- relaxometry (1)
- religion (1)
- remote monitoring (1)
- renal (1)
- renal function (1)
- research (1)
- research infrastructure (1)
- right heart impairment (1)
- right ventricular dysfunction (1)
- risk prediction scores (1)
- rumenic acid (1)
- sacubitril-valsartan (1)
- scanner (1)
- secondary data usage (1)
- self‐gated (1)
- semantic interoperability (1)
- semantic segmentation (1)
- sensitivity analysis (1)
- sex differences (1)
- shimming (1)
- short Synacthen test (1)
- sigma-1 receptor-directed molecular imaging (1)
- signal filtering (1)
- signal to noise ratio (1)
- six-minute walk test (1)
- skeletal (1)
- skinned fiber (1)
- small animal (1)
- small animal SPECT (1)
- small-animal imaging (1)
- social support (1)
- sodium-glucose co-transporter-2 inhibitors (1)
- somatostatin receptor (SSTR) (1)
- speckle tracking (1)
- speech recognition (1)
- sphingolipids (1)
- spin lock (1)
- spin-lock (1)
- spiral ganglion neuron (1)
- spironolactone (1)
- sports and exercise medicine (1)
- state space (1)
- statins (1)
- statistical data (1)
- statistical mechanics (1)
- stem cells (1)
- stem-cell research (1)
- stenosis (1)
- stepped impedance resonators (1)
- stroke (1)
- structure–activity relationships (1)
- study-group ADSR (1)
- sudden cardiac death (1)
- surgical aneurysm treatment (1)
- swine (1)
- sympathetic nervous system (1)
- systems biology (1)
- tandem peptide (1)
- targeted gene panel (1)
- therapy (1)
- therapy response (1)
- thermodynamics (1)
- thromboembolism (1)
- thrombolysis (1)
- time (1)
- trait emotional intelligence (1)
- transceiver array (1)
- transcription (1)
- transfer learning (1)
- transformations (1)
- transient ischemic attack (1)
- translational (1)
- ultrahigh field (1)
- ultrahigh-field (1)
- ultrahigh-field MRI (1)
- ultrasound (1)
- under-dosing (1)
- undersampling (1)
- urology (1)
- usability (1)
- user-centered design (1)
- vena contracta area (1)
- warfarin interruption (1)
- wave interference (1)
- wave‐CAIPI (1)
- weaning (1)
- zebrafish (1)
- Überleben (1)
- α-Ketoglutarate dehydrogenase (1)
- β1-adrenoceptor/β1-adrenergic receptor (1)
- βAR (1)
Institute
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (151) (remove)
Sonstige beteiligte Institutionen
- Clinical Trial Center (CTC) / Zentrale für Klinische Studien Würzburg (ZKSW) (2)
- Center for Interdisciplinary Clinical Research, Würzburg University, Würzburg, Germany (1)
- Datenintegrationszentrum Würzburg (DIZ) (1)
- Department of Medicinal Chemistry, University of Vienna, Althanstraße 14, 1090 Vienna, Austria (1)
- Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, Althanstraße 14, 1090 Vienna, Austria (1)
- Interdisziplinäre Biomaterial- und Datenbank Würzburg (ibdw) (1)
- Interdisziplinäre Zentrum für Klinische Forschung (IZKF) (1)
- Interdisziplinäres Zentrum für Klinische Forschung (IZKF) (1)
- Klinische Studienzentrale (Universitätsklinikum) (1)
- Servicezentrum Medizin-Informatik (1)
Anxious depression represents a subtype of major depressive disorder and is associated with increased suicidality, severity, chronicity and lower treatment response. Only a few studies have investigated the differences between anxious depressed (aMDD) and non-anxious depressed (naMDD) patients regarding treatment dosage, serum-concentration and drug-specific treatment response. In our naturalistic and prospective study, we investigated whether the effectiveness of therapy including antidepressants (SSRI, SNRI, NaSSA, tricyclics and combinations) in aMDD patients differs significantly from that in naMDD patients. In a sample of 346 patients, we calculated the anxiety somatization factor (ASF) and defined treatment response as a reduction (≥50%) in the Hamilton Depression Rating Scale (HDRS)-21 score after 7 weeks of pharmacological treatment. We did not observe an association between therapy response and the baseline ASF-scores, or differences in therapy outcomes between aMDD and naMDD patients. However, non-responders had higher ASF-scores, and at week 7 aMDD patients displayed a worse therapy outcome than naMDD patients. In subgroup analyses for different antidepressant drugs, venlafaxine-treated aMDD patients showed a significantly worse outcome at week 7. Future prospective, randomized-controlled studies should address the question of a worse therapy outcome in aMDD patients for different psychopharmaceuticals individually.
Ultra-high field cardiac MRI in large animals and humans for translational cardiovascular research
(2023)
A key step in translational cardiovascular research is the use of large animal models to better understand normal and abnormal physiology, to test drugs or interventions, or to perform studies which would be considered unethical in human subjects. Ultrahigh field magnetic resonance imaging (UHF-MRI) at 7 T field strength is becoming increasingly available for imaging of the heart and, when compared to clinically established field strengths, promises better image quality and image information content, more precise functional analysis, potentially new image contrasts, and as all in-vivo imaging techniques, a reduction of the number of animals per study because of the possibility to scan every animal repeatedly. We present here a solution to the dual use problem of whole-body UHF-MRI systems, which are typically installed in clinical environments, to both UHF-MRI in large animals and humans. Moreover, we provide evidence that in such a research infrastructure UHF-MRI, and ideally combined with a standard small-bore UHF-MRI system, can contribute to a variety of spatial scales in translational cardiovascular research: from cardiac organoids, Zebra fish and rodent hearts to large animal models such as pigs and humans. We present pilot data from serial CINE, late gadolinium enhancement, and susceptibility weighted UHF-MRI in a myocardial infarction model over eight weeks. In 14 pigs which were delivered from a breeding facility in a national SARS-CoV-2 hotspot, we found no infection in the incoming pigs. Human scanning using CINE and phase contrast flow measurements provided good image quality of the left and right ventricle. Agreement of functional analysis between CINE and phase contrast MRI was excellent. MRI in arrested hearts or excised vascular tissue for MRI-based histologic imaging, structural imaging of myofiber and vascular smooth muscle cell architecture using high-resolution diffusion tensor imaging, and UHF-MRI for monitoring free radicals as a surrogate for MRI of reactive oxygen species in studies of oxidative stress are demonstrated. We conclude that UHF-MRI has the potential to become an important precision imaging modality in translational cardiovascular research.
T cell exhaustion is a hallmark of cancer and persistent infections, marked by inhibitory receptor upregulation, diminished cytokine secretion, and impaired cytolytic activity. Terminally exhausted T cells are steadily replenished by a precursor population (Tpex), but the metabolic principles governing Tpex maintenance and the regulatory circuits that control their exhaustion remain incompletely understood. Using a combination of gene-deficient mice, single-cell transcriptomics, and metabolomic analyses, we show that mitochondrial insufficiency is a cell-intrinsic trigger that initiates the functional exhaustion of T cells. At the molecular level, we find that mitochondrial dysfunction causes redox stress, which inhibits the proteasomal degradation of hypoxia-inducible factor 1α (HIF-1α) and promotes the transcriptional and metabolic reprogramming of Tpex cells into terminally exhausted T cells. Our findings also bear clinical significance, as metabolic engineering of chimeric antigen receptor (CAR) T cells is a promising strategy to enhance the stemness and functionality of Tpex cells for cancer immunotherapy.
Psychosocial factors affect mental health and health-related quality of life (HRQL) in a complex manner, yet gender differences in these interactions remain poorly understood. We investigated whether psychosocial factors such as social support and personal and work-related concerns impact mental health and HRQL differentially in women and men during the first year of the COVID-19 pandemic. Between June and October 2020, the first part of a COVID-19-specific program was conducted within the “Characteristics and Course of Heart Failure Stages A-B and Determinants of Progression (STAAB)” cohort study, a representative age- and gender-stratified sample of the general population of Würzburg, Germany. Using psychometric networks, we first established the complex relations between personal social support, personal and work-related concerns, and their interactions with anxiety, depression, and HRQL. Second, we tested for gender differences by comparing expected influence, edge weight differences, and stability of the networks. The network comparison revealed a significant difference in the overall network structure. The male (N = 1370) but not the female network (N = 1520) showed a positive link between work-related concern and anxiety. In both networks, anxiety was the most central variable. These findings provide further evidence that the complex interplay of psychosocial factors with mental health and HRQL decisively depends on gender. Our results are relevant for the development of gender-specific interventions to increase resilience in times of pandemic crisis.
Long-term sequelae in hospitalized Coronavirus Disease 2019 (COVID-19) patients may result in limited quality of life. The current study aimed to determine health-related quality of life (HRQoL) after COVID-19 hospitalization in non-intensive care unit (ICU) and ICU patients. This is a single-center study at the University Hospital of Wuerzburg, Germany. Patients eligible were hospitalized with COVID-19 between March 2020 and December 2020. Patients were interviewed 3 and 12 months after hospital discharge. Questionnaires included the European Quality of Life 5 Dimensions 5 Level (EQ-5D-5L), patient health questionnaire-9 (PHQ-9), the generalized anxiety disorder 7 scale (GAD-7), FACIT fatigue scale, perceived stress scale (PSS-10) and posttraumatic symptom scale 10 (PTSS-10). 85 patients were included in the study. The EQ5D-5L-Index significantly differed between non-ICU (0.78 ± 0.33 and 0.84 ± 0.23) and ICU (0.71 ± 0.27; 0.74 ± 0.2) patients after 3- and 12-months. Of non-ICU 87% and 80% of ICU survivors lived at home without support after 12 months. One-third of ICU and half of the non-ICU patients returned to work. A higher percentage of ICU patients was limited in their activities of daily living compared to non-ICU patients. Depression and fatigue were present in one fifth of the ICU patients. Stress levels remained high with only 24% of non-ICU and 3% of ICU patients (p = 0.0186) having low perceived stress. Posttraumatic symptoms were present in 5% of non-ICU and 10% of ICU patients. HRQoL is limited in COVID-19 ICU patients 3- and 12-months post COVID-19 hospitalization, with significantly less improvement at 12-months compared to non-ICU patients. Mental disorders were common highlighting the complexity of post-COVID-19 symptoms as well as the necessity to educate patients and primary care providers about monitoring mental well-being post COVID-19.
Highlights
• Loss of DNAJC19's DnaJ domain disrupts cardiac mitochondrial structure, leading to abnormal cristae formation in iPSC-CMs.
• Impaired mitochondrial structures lead to an increased mitochondrial respiration, ROS and an elevated membrane potential.
• Mutant iPSC-CMs show sarcomere dysfunction and a trend to more arrhythmias, resembling DCMA-associated cardiomyopathy.
Background
Dilated cardiomyopathy with ataxia (DCMA) is an autosomal recessive disorder arising from truncating mutations in DNAJC19, which encodes an inner mitochondrial membrane protein. Clinical features include an early onset, often life-threatening, cardiomyopathy associated with other metabolic features. Here, we aim to understand the metabolic and pathophysiological mechanisms of mutant DNAJC19 for the development of cardiomyopathy.
Methods
We generated induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) of two affected siblings with DCMA and a gene-edited truncation variant (tv) of DNAJC19 which all lack the conserved DnaJ interaction domain. The mutant iPSC-CMs and their respective control cells were subjected to various analyses, including assessments of morphology, metabolic function, and physiological consequences such as Ca\(^{2+}\) kinetics, contractility, and arrhythmic potential. Validation of respiration analysis was done in a gene-edited HeLa cell line (DNAJC19tv\(_{HeLa}\)).
Results
Structural analyses revealed mitochondrial fragmentation and abnormal cristae formation associated with an overall reduced mitochondrial protein expression in mutant iPSC-CMs. Morphological alterations were associated with higher oxygen consumption rates (OCRs) in all three mutant iPSC-CMs, indicating higher electron transport chain activity to meet cellular ATP demands. Additionally, increased extracellular acidification rates suggested an increase in overall metabolic flux, while radioactive tracer uptake studies revealed decreased fatty acid uptake and utilization of glucose. Mutant iPSC-CMs also showed increased reactive oxygen species (ROS) and an elevated mitochondrial membrane potential. Increased mitochondrial respiration with pyruvate and malate as substrates was observed in mutant DNAJC19tv HeLa cells in addition to an upregulation of respiratory chain complexes, while cellular ATP-levels remain the same. Moreover, mitochondrial alterations were associated with increased beating frequencies, elevated diastolic Ca\(^{2+}\) concentrations, reduced sarcomere shortening and an increased beat-to-beat rate variability in mutant cell lines in response to β-adrenergic stimulation.
Conclusions
Loss of the DnaJ domain disturbs cardiac mitochondrial structure with abnormal cristae formation and leads to mitochondrial dysfunction, suggesting that DNAJC19 plays an essential role in mitochondrial morphogenesis and biogenesis. Moreover, increased mitochondrial respiration, altered substrate utilization, increased ROS production and abnormal Ca\(^{2+}\) kinetics provide insights into the pathogenesis of DCMA-related cardiomyopathy.
Background
Guideline-directed medical therapy (GDMT) is the cornerstone in the treatment of patients with heart failure and reduced ejection fraction (HFrEF) and novel substances such as sacubitril/valsartan (S/V) and sodium-glucose co-transporter-2 inhibitors (SGLT2i) have demonstrated marked clinical benefits. We investigated their implementation into real-world HF care in Germany before, during, and after the COVID-19 pandemic period.
Methods
The IQVIA LRx data set is based on ∼80% of 73 million people covered by the German statutory health insurance. Prescriptions of S/V were used as a proxy for HFrEF. Time trends were analysed between Q1/2016 and Q2/2023 for prescriptions for S/V alone and in combination therapy with SGLT2i.
Findings
The number of patients treated with S/V increased from 5260 in Q1/2016 to 351,262 in Q2/2023. The share of patients with combination therapy grew from 0.6% (29 of 5260) to 14.2% (31,128 of 219,762) in Q2/2021, and then showed a steep surge up to 54.8% (192,429 of 351,262) in Q2/2023, coinciding with the release of the European Society of Cardiology (ESC) guidelines for HF in Q3/2021. Women and patients aged >80 years were treated less often with combined therapy than men and younger patients. With the start of the COVID-19 pandemic, the number of patients with new S/V prescriptions dropped by 17.5% within one quarter, i.e., from 26,855 in Q1/2020 to 22,145 in Q2/2020, and returned to pre-pandemic levels only in Q1/2021.
Interpretation
The COVID-19 pandemic was associated with a 12-month deceleration of S/V uptake in Germany. Following the release of the ESC HF guidelines, the combined prescription of S/V and SGLT2i was readily adopted. Further efforts are needed to fully implement GDMT and strengthen the resilience of healthcare systems during public health crises.
Barth Syndrome (BTHS) is an inherited X-chromosomal linked disorder, characterized by early development of cardiomyopathy, immune system defects, skeletal muscle myopathy and growth retardation. The disease displays a wide variety of symptoms including heart failure, exercise intolerance and fatigue due to the muscle weakness. The cause of the disease are mutations in the gene encoding for the mitochondrial transacylase Tafazzin (TAZ), which is important for remodeling of the phospholipid cardiolipin (CL). All mutations result in a pronounced decrease of the functional enzyme leading to an increase of monolysocardiolipin (MLCL), the precursor of mature CL, and a decrease in mature CL itself. CL is a hallmark phospholipid of mitochondrial membranes, highly enriched in the inner mitochondrial membrane (IMM). It is not only important for the formation of the cristae structures, but also for the function of different protein complexes associated with the mitochondrial membrane. Reduced levels of mature CL cause remodeling of the respiratory chain supercomplexes, impaired respiration, defects in the Krebs cycle and a loss of mitochondrial calcium uniporter (MCU) protein. The defective Ca2+ handling causes impaired redox homeostasis and energy metabolism resulting in cellular arrhythmias and defective electrical conduction. In an uncompensated situation, blunting mitochondrial Ca2+ uptake provokes increased mitochondrial emission of H2O2 during workload transitions, related to oxidation of NADPH, which is required to regenerate anti-oxidative enzymes. However, in the hearts and cardiac myocytes of mice with a global knock-down of the Taz gene (Taz-KD), no increase in mitochondrial ROS was observed, suggesting that other metabolic pathways may have compensated for reduced Krebs cycle activation.
The healthy heart produces most of its energy by consuming fatty acids. In this study, the fatty acid uptake into mitochondria and their further degradation was investigated, which showed a switch of the metabolism in general in the Taz-KD mouse model. In vivo studies revealed an increase of glucose uptake into the heart and decreased fatty acid uptake and oxidation. Disturbed energy conversion resulted in activation of retrograde signaling pathways, implicating overall changes in the cell metabolism. Upregulated integrated stress response (ISR) was confirmed by increased levels of the downstream target, i.e., the activating transcription factor 4 (ATF4). A Tafazzin knockout mouse embryonal fibroblast cell model (TazKO) was used to inhibit the ISR using siRNA transfection or pharmaceutical inhibition. This verified the central role of
II
the ISR in regulating the metabolism in BTHS. Moreover, an increased metabolic flux into glutathione biosynthesis was observed, which supports redox homeostasis. In vivo PET-CT scans depicted elevated activity of the xCT system in the BTHS mouse heart, which transports essential amino acids for the biosynthesis of glutathione precursors. Furthermore, the stress induced signaling pathway also affected the glutamate metabolism, which fuels into the Krebs cycle via -ketoglutarate and therefore supports energy converting pathways. In summary, this thesis provides novel insights into the energy metabolism and redox homeostasis in Barth syndrome cardiomyopathy and its regulation by the integrated stress response, which plays a central role in the metabolic alterations. The aim of the thesis was to improve the understanding of these metabolic changes and to identify novel targets, which can provide new possibilities for therapeutic intervention in Barth syndrome.